Tag Archives: U.S. policy

Barbara Bush Addresses END7 Student Leaders

Barbara Bush,  CEO and co-founder of Global Health Corps, addressed END7 student leaders on March 1, 2016 at the closing reception of the second annual END7 Student Advocacy Day.

Barbara Bush

Barbara Bush, CEO and co-founder of Global Health Corps

I am so thrilled to be here with y’all at the Global Network for Neglected Tropical Diseases’ Second Annual END7 Student Advocacy Day. I’m Barbara Bush and I’m the CEO & co-Founder of Global Health Corps. I am honored to be here with you today to celebrate the 10th anniversary of the USAID NTD program, a unique public-private partnership that has successfully leveraged more than 11.1 billion worth of donated drugs and supported the distribution of 1.4 billion safe and effective NTD treatments to more than 687 million people throughout Africa, Asia and Latin America.

It seems oddly fitting and very humbling that I am with you today to celebrate this program that my father launched a decade ago as he was the catalyst for my involvement with global health, an interest that was born rather unexpectedly. In 2003, as a 21-year-old architecture major, I was lucky enough to take 2 weeks off of my fancy Summer internship designing beautiful buildings and clothing in NYC, to be on the ground for the launch of PEPFAR—the President’s Emergency Plan for AIDS relief–in five countries in East and Central Africa, and witnessed first-hand the roadblocks so many people face in obtaining appropriate healthcare to lead happy, prosperous lives.

It was a harrowing image–seeing hundreds of people lining the street waiting for life-saving medicine that had been readily available in the U.S for years. I vividly remember standing with my mother next to a tiny precious girl and her mother. The little girl was lying down dressed in her fanciest white and lavender dress. I didn’t know the details of that child’s life, only that she was too sick to stand, and though she looked like she was 3, she was probably 7. Her mother dressed her up and brought her to the launch, though she probably didn’t live much longer. People’s lives, like that little girl’s, were limited and cut short, simply because of factors beyond all of our control – like where and when we are born.

Yet, these heartbreaking memories were set against inspiring memories, memories of witnessing the commitment health workers, family members, and community members had made to change this unacceptable status quo.

Following that trip, I became obsessed with working on global health issues. And, quickly realized that I was only one of hundreds of thousands of people in my generation eager to fight to make health a human right; a fact demonstrated by the tremendous growth of global health programs on US college campuses, as well as by the engaged minds sitting here this evening.

Global Health Corps is building the next generation of global health leaders who share a common belief: health is a human right. At Global Health Corps, we are motivated by the conviction that great ideas don’t change the world, great people do.

However, our belief that health is a human right is not reflected in today’s reality – millions’ potentials and futures are undermined simply because they do not have access to the healthcare that they deserve. This is a truth y’all know too well as more than 1 billion people are at risk of NTDs’ debilitating effects, despite the fact that they are easily prevented through cost-effective interventions. This inequity of healthcare access persists in developing countries just as it does here in the United States; as it does in this very city.

Yet, right now is an incredible time to be working in global health (and alive, for that matter), we have vaccines that prevent childhood diseases that just a generation – or even half a generation – ago were fatal. In 2016, we actually have the technology, medicines, and interventions to not only save lives, but ensure people everywhere thrive – living healthier, more joyful, and more connected days. In many ways, life today is better than it has ever been. And, yet, millions die from preventable, treatable illnesses such as NTDs. Health systems are weak and we need new leaders to fix them.

The complexity and scope of today’s Global Health problems require people with diverse experiences, including an array of hard skills which are not clinical but still profoundly critical in the health care setting: operations, project management, engineering, communications, and architecture to name a few.

We believe that most powerful lever of change in global health is leadership: exceptional, talented problem solvers who can inspire and collaborate with others, and really move the needle in a new way. Getting the right talent in the right positions in the health system.

In 2009, five other twentysomethings and I founded Global Health Corps, a leadership development institute, to harness the passion, energy, and skill-sets of our generation to confront the world’s massive global health challenges.

Since then, we have been growing the movement for health equity, with many bumps and victories along the way. Six years ago, GHC had two staff members, including myself, and 22 inaugural fellows who took a chance on us. Today our team is ten times that size and our global community of fellows and alumni is nearly 600 strong.

These 600 young leaders have been placed at high-impact organizations in Rwanda, Malawi, Uganda, Burundi, Zambia, and the United States for a year-long fellowship. We partner with organizations on the front lines of health equity, across issue areas including NTDs and WASH and ranging from large international organizations such as Partners In Health to government agencies such as Ministries of Health to small grassroots non-profits such as Nyaka AIDS Project in Uganda. Our partners identify capacity gaps that they have and then we competitively recruit two young leaders, between the ages of 21 and 30, to serve with them for a year to address those needs. In this way, we are seeding the global health field with new talent and fresh ways of thinking and responding to real-time, demand driven needs in the global health field. Our fellows always serve in teams of two—one fellow from the country where they work, partnered with an international fellow—making this a truly global group of young leaders. Throughout the fellowship year, we invest heavily in training, coaching, and mentoring our fellows, ensuring they understand policy-making, advocacy, and intra-and entrepreneurship because we know their year with Global Health Corps is just the launching point for a career as a changemaker in global health.

Our fellows embody a vision of leadership we’ve crafted over the years based on the evolving needs of the global health field. It’s 2015. Post-Ebola crisis, post-Millennium Development Goals, at the dawn of the Sustainable Development Goal era, with Africa rising, we strongly believe that to see the progress we need to see – and to ensure access to healthcare for all – we need a change. We need a cadre of leaders placed in the right gaps in the health system to move us forward. It’s an exciting moment.

But we aren’t focusing on building any leader. In our view, a leader possesses several key qualities: Compassion. Vulnerability. Resilience. Collaboration. Creativity. Commitment to social justice. Business acumen. These qualities have not been automatically linked to leadership in the past – especially traits like vulnerability, compassion, and resiliency.

This past June, we welcomed our 7th class of 134 fellows who are serving at 62 organizations. And quick side note that three-quarters of this year’s class are brilliant, inspiring women. This year we received more than 14,000 applications for 168 positions in our 2016-2017 fellowship class. We will accept less than 3% of these applicants. In short, our fellows are exceptional. From counselling homeless youth on chronic disease management in Newark, New Jersey, to building an electronic medical records system in Malawi, to screening and treating cervical cancer in Zambia, our fellows are positively affecting the health of thousands of people around the world. GHC fellows represent the powerful notion that young people can make an impact in the field of global health now, while gaining necessary skills to be leaders throughout their lives.

You might be wondering what the next generation of global health leaders looks like. Well, they are pretty diverse. They are writers, architects, economists, healthcare practitioners. They have founded organizations, completed other prestigious fellowships, won African Grammies, and given TED talks. You may know some of them – you may one day be some of them.

One of the biggest obstacles to this goal is that a lot of people who want to make a difference in this field are under the impression that they can’t.  They think that only people with medical training—doctors and nurses—can help the sick and suffering.  So part of our work is education—showing people that this simply isn’t true.

The complexity and scope of today’s problems require people with diverse experiences, from a wide range of fields beyond medicine. Finding innovative, sustainable solutions demands skills ranging from education and psychology … to supply-chain management …to computer programming … to engineering and beyond. I’m sure some of these skills can be found right here in this room.

Global Health Corps is working to change this perception. Ameet Salvi, who studied engineering at UC Berkeley and went on to work for the GAP in supply-chain management. After three years in retail, he began looking for a way to use his skills to make a difference in the lives of others. He heard about Global Health Corps, applied, and was accepted as one of our 22 inaugural fellows.

Only weeks after leaving his job, Ameet moved to Tanzania.  His task was to do for the 1 million people living on the island of Zanzibar exactly what he did for GAP.  But instead of working to get jeans into stores, Ameet used his skills to get life-saving medicines to health clinics—and into the hands of the patients who needed them most. Today, Ameet works as the Supply Chain Manager for Partners In Health in Sierra Leone, where he moved when the Ebola crisis hit West Africa. Ameet represents the powerful notion that bright and motivated young people can make a profound and immediate impact working in the field of global health and build skills to become new leaders in the industry.

Our fellows look like Jasmine Burton who is currently serving as a Design Specialist with Population Services International in Zambia. As a product designer, Jasmine wrestled with how products could be designed and created to solve health issues. These questions led her to discover her unique passion for toilets. In 2014, she won the Georgia Tech InVenture Prize competition for her design of an inexpensive mobile toilet. As founder of Wish For WASH, Jasmine strives to bring innovative solutions to the sanitation crisis; a crisis that impacts the spread and prevention of NTDs. Jasmine’s skills as a product designer were turned into life-changing superpowers when paired with her creativity & belief in health equity.

Our fellows also look like Regina Yang and Amelie Ntigulirwa, architects from the United States and Rwanda. These women served their fellowship year with MASS Design Group using their backgrounds in architecture and design to make small and inexpensive changes in the way that air flows throughout health centers so airborne illnesses like TB, which affects a 1/3 of Rwanda’s population, don’t spread to everyone that enters the hospital. Excitingly, the Ministry of Health was so impressed by the drop in TB incidences and the improvement in health outcomes due to these design tweaks that airflow is now a factor in all new health facilities built throughout the country. Both Regina and Amelie remained at MASS Design after their fellowship and are still currently working there, alongside the new generation of GHC fellows. Amelie and Marie are making an impact in the health field now and wherever their careers take them, they will be champions of the global-health cause for the rest of their lives. But we need to recruit many more people like them. As we recruit more people like them to join the global health field, the possibilities for innovative and creative solutions grows exponentially and that is inspiring. And the talented people we have working to solve these challenges, the more lives we can save.

In 20 years, we will see a dramatic improvement in health systems, in terms of quality and affordability of care. This will be the result of an infusion of radical new leadership, a group of leaders that Global Health Corps is working to build. In 10-15 years, young leaders like Sarah Snidal, currently at CHAI with its Global Vaccines Delivery team where she focuses on identifying and mitigating systematic bottlenecks and sharing best practices across regions and stakeholders, will be the Director of the World Health Organizations overseeing that NTDs no longer needlessly rob people of their health and lives. And Marie Amelie, the Rwandan architect at MASS Design Group, will be the Minister of Finance in Rwanda, funding smart clinic designs that stem disease spread. And Estefania Palomino, a Colombian human rights lawyer working on reproductive health in the US, will be the UN High Commissioner on Human Rights ensuring that health as a human right is realized in every way.  And All this while Ameet Salvi, who’s been working on the frontlines of the Ebola crisis will be running Partners in Health. And finally, James Arianaitwe will be Uganda’s Minister of Health, revitalizing infrastructure and empowering frontline workers. These and many other impressive individuals are becoming empowered to advocate and fight for change.

This community of young leaders inspires and energizes me. Knowing that I’m standing in front of a community of equally engaged, thoughtful, and committed individuals eager to improve lives worldwide also inspires me. It is critical that you continue to advocate and work for change by meeting with your representatives in Congress and amplifying your voice and the voices of other END7 supporters through petitions and op-eds.  We have so much at our disposal to achieve great things, and we also have the possibility to reimagine leadership that can accomplish even more, including eliminating NTDs. This is exciting, even if it is a bit daunting. But I know, beyond a doubt, that we are up for the task. Thank you.

Barbara Bush to Keynote 2016 END7 Student Advocacy Day

Barbara Bush social media announcement

We are excited to announce that Barbara Bush will give the keynote address at the second annual END7 Student Advocacy Day on Tuesday, March 1. Ms. Bush is the CEO and co-founder of Global Health Corps (GHC). GHC is a leadership development organization focused on building the next generation of global health leaders. GHC competitively recruits highly talented 21 to 30-year-olds from across sectors, geographies, and backgrounds and through a yearlong paid fellowship places them in high-impact positions with organizations on the front lines of global health equity in Malawi, Rwanda, Uganda, the United States, and Zambia.

Ms. Bush has previously worked and traveled with the Smithsonian Institution’s Cooper-Hewitt, National Design Museum, the Red Cross Children’s Hospital in Capetown, South Africa, UNICEF in Botswana, and the UN World Food Programme. Ms. Bush is a member of UNICEF’s Next Generation Steering Committee and is on the Board of Directors of Covenant House International, PSI, Friends of the Global Fight for AIDS, TB, and Malaria, and the UN’s Global Entrepreneurship Council. She is a Draper Richards Foundation Social Entrepreneur, a World Economic Forum Young Global Shaper, and a fellow of the Echoing Green Foundation. She was named one of Glamour Magazine’s Women of the Year in 2011 and one of Newsweek’s Women of Impact in 2013. Ms. Bush graduated from Yale University with a degree in Humanities in 2004.

President George W. Bush launched the United States Agency for International Development’s Neglected Tropical Disease Program in 2006. The Program has since delivered more than 1.3 billion NTD treatments in 32 countries.  At the END7 Student Advocacy Day closing reception in the Longworth House Office Building, Ms. Bush will share a reflection on shaping the next generation of global health leaders. We are honored to have her join us and meet END7 student leaders from across the United States after they meet with their representatives in Congress to advocate for funding for the USAID NTD Program.

RSVP now for the 2016 END7 Student Advocacy Day at bit.ly/END7StudentAdvocacyDay. All U.S.-based undergraduate and graduate students are invited to attend. See photos from the 2015 END7 Student Advocacy Day on Facebook.

FY 2016 Budget Maintains Critical Funding to Fight NTDs

The U.S. Congress just passed a federal budget that maintains critical funding to fight neglected tropical diseases (NTDs) in financial year (FY) 2016.

Thousands of END7 supporters wrote to the president and members of Congress this year to oppose cuts to the United States Agency for International Development’s (USAID) Neglected Tropical Disease Program. With its funding maintained for another year, the program will continue to deliver donated medicine to millions of people in more than 25 countries to control and eliminate the most common diseases of poverty.

For the fourth year in a row, President Obama had recommended significant cuts to the USAID NTD Program that would have threatened the progress to control and eliminate these diseases by 2020. This is the third consecutive year that Congress has increased funding over the president’s proposal, a testament to the bipartisan support for the highly successful NTD Program.

USAID’s NTD Program is a unique public-private partnership. Over the last 10 years, the United States has demonstrated exemplary leadership in increasing access to medicines to treat the seven most common NTDs, including ascariasis, trichuriasis, hookworm, schistosomiasis, lymphatic filariasis, trachoma and onchocerciasis. Robust funding and support from the U.S. government has been critical to leveraging more than $8.8 billion in NTD treatments donated by pharmaceutical companies. Moreover, the U.S. government’s strong commitment is critical to bringing other donors to the table, including governments of other G7 countries, and closing the global annual funding gap currently estimated at $220 million.

NTD control is one of the simplest and most cost-effective investments in global health and development. Investments in NTD programs have significant cross-cutting impact on other development efforts, including maternal and child health; nutrition; education; and water, sanitation and hygiene.

Strong commitment from the U.S. government and the generosity and compassion of the American people has enabled us to build on significant progress in eliminating these diseases as public health threats. With continued support in this fiscal year, we have the opportunity to control and eliminate many of the most common NTDs in a timetable measured by years, not decades.

Treating NTDs has huge impacts on the lives of those living in extreme poverty. Fewer people will go blind, fewer people will be disabled and disfigured and progress to control and eliminate the most common NTDs by 2020 will continue.

Nobel Honors for Medicine Elevate NTD Elimination to the Next Level

by Baroness Helene Hayman

In an age when sophisticated medical breakthroughs routinely redefine what we once thought was possible, a humble set of pills serves as a reminder that low-tech heath interventions can have a massive impact on much of the world’s population, particularly those living in extreme poverty.

Nearly 40 years ago, William C. Campbell and Satoshi Ōmura found that a drug used to treat parasites in animals could be adapted to treat people for two devastating parasitic diseases, onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis), ultimately resulting in the creation of the drug ivermectin. For their achievements, Drs. Campbell and Ōmura shared the 2015 Nobel Prize in Physiology or Medicine with another groundbreaking researcher, Tu Youyou, who discovered the first drug treatment for malaria.

Ivermectin has since become part of an array of safe and effective drugs that treat a range of parasitic and bacterial diseases, commonly known as neglected tropical diseases (NTDs), which also include hookworm, ascariasis, trichuriasis, schistosomiasis and trachoma.

Today, we are on the cusp of controlling and eliminating several NTDs in countries around the world using these simple, low-cost drugs, which are being donated by the billions from pharmaceutical companies.

The United States and the United Kingdom have demonstrated remarkable leadership and commitment to the fight against NTDs through the support of the 2012 London Declaration, which calls for the control or elimination of ten NTDs by 2020. Germany put neglected and poverty-related diseases in the spotlight by including them as a key discussion item at this year’s G7 Summit. And the recent announcement of the Ross Fund — a £1 billion fund for malaria and other infectious diseases, including NTDs, created by the UK’s Department for International Development (DFID) and the Bill & Melinda Gates Foundation — is another step in the right direction.

Reaching the 2020 control and elimination targets for NTDs set by the World Health Organization would be one of the greatest public health victories of our time, but we are at risk of letting this potential triumph slip through our fingers if urgent action is not taken for more countries to join the United States, United Kingdom and Germany in supporting global NTD programs.

It comes down to this: governments — of both donor and endemic countries — must dedicate more funding to ensure that donated drugs reach at-risk communities on a timely and consistent basis. Given the links that NTDs have with HIV/AIDS and malaria, now is the time to have a sensible discussion about including NTDs as part of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

The best news is that, largely due to the generosity of the pharmaceutical companies, the gap for funding global NTD programs is remarkably small — estimated at only $US220 million per year for the next five years. In a time of economic austerity, investing in this global health bargain would deliver transformative results, ridding a billion people of the daily burden of preventable parasitic diseases while providing real hope for significant improvements in economic development and equity.

Baroness Helene Hayman is a Crossbench Member of the House of Lords, Vice Chair of the All Party Parliamentary Group on Malaria and NTDs, and a Trustee of Sabin Foundation Europe.